Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Clinical relevance of performing endoscopic ultrasound-guided fine-needle biopsy for pancreatic neuroendocrine tumors less than 2?cm. Journal of surgical oncology Heidsma, C. M., Tsilimigras, D. I., Rocha, F. n., Abbott, D. E., Fields, R. n., Smith, P. M., Poultsides, G. A., Cho, C. n., van Eijck, C. n., van Dijkum, E. N., Maithel, S. K., Pawlik, T. M. 2020

Abstract

We sought to define the diagnostic yield and concordance rates between endoscopic ultrasound (EUS)-fine-needle aspiration (FNA) and surgical pathology specimen following resection of pancreatic neuroendocrine tumors (pNET) less than 2?cm.Patients with a pNET less than 2?cm who underwent EUS-FNA were identified using a multi-institutional international database. Tumor differentiation, and Ki-67 index, as determined through EUS-FNA were examined and concordance rates between EUS-FNA and the surgical pathology were assessed.Among 628 patients with a pNET less than 2?cm, 57.2% of patients had an EUS-FNA performed. Patients who underwent EUS had slightly smaller size tumors (1.3 vs 1.4?cm), and the pNETs were less likely to be functional (15.3% vs 26.8%) or symptomatic (48.5% vs 56.5%) (both P?

View details for DOI 10.1002/jso.26158

View details for PubMedID 32783272